February 2024 SOCRA Source Journal - Journal - Page 59
REFERENCES
9. A study to evaluate Pertuzumab + Trastuzumab + Docetaxel vs. placebo + Trastuzumab + Docetaxel
in previously untreated HER2-positive metastatic breast cancer (CLEOPATRA). ClinicalTrials.gov. https://
clinicaltrials.gov/ct2/show/results/NCT00567190. Last Updated December 13, 2019. Accessed April 18,
2022.
10. BATTLE-2 program: a biomarker-integrated targeted therapy study in previously treated patients
with advanced non-small cell lung cancer. ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/results/
NCT01248247. Last Updated January 12, 2022. Accessed April 18, 2022.
11.S wain S, Baselga J, Kim S, et al. Pertuzumab, Trastuzumab, and Docetaxel in HER2-positive metastatic
breast cancer. The New England Journal of Medicine. 2015;372(8):724–734. doi:10.1056/NEJMoa1413513
12. Kim E, Herbst R, Wistuba I, et al. The BATTLE trial: personalizing therapy for lung cancer. HHS Author
Manuscripts. 2011;1(1):44–53. doi:10.1158/2159-8274
13. Representation and diversity in clinical trials. STAT. https://www.statnews.com/wp-content/
uploads/2020/11/STAT-eBook-representation_diversity_clinical_trials.pdf. Accessed April 18, 2022.
14. Marbito M. COVID-19 pandemic led to more inclusive practices in clinical trials. Haelio News. https://
www.healio.com/news/primary-care/20220125/covid19-pandemic-led-to-more-inclusive-practices-in-clinicaltrials. Published January 25, 2022. Accessed April 18, 2022.
15. A timeline of covid-19 developments in 2020. AJMC. https://www.ajmc.com/view/a-timeline-of-covid19developments-in-2020. Published January 1, 2021. Accessed October 12, 2021.
16. Covid-19 and clinical trials: The medidata perspective. https://www.medidata.com/wp-content/
uploads/2020/08/COVID19-Response8.0_Clinical-Trials_2020824_v1.pdf. Published August 18, 2020.
Accessed October 12, 2021.
17. Conduct of clinical trials of medical products during the COVID-19 public health emergency. https://
www.fda.gov/media/136238/download. Published March 2020. Accessed October 12, 2021.
18. Interim guidance for patients on clinical trials supported by the NCI cancer therapy evaluation
program and the NCI community oncology research program (NCORP). https://ctep.cancer.gov/
content/docs/Memorandum_on_Interim_Guidance_for_Clinical_Trial_Activities_Affected_by_the_Novel_
Coronavirus-3-13-2020.pdf. Published March 13, 2020. Accessed October 12, 2021.
19. McCaskill-Stevens W, Pinto H, Marcus AC, et al. Recruiting minority cancer patients into cancer
clinical trials: A pilot project involving the Eastern Cooperative Oncology Group and the National Medical
Association. Journal of Clinical Oncology. 1999;17(3):1029–1029. doi:10.1200/jco.1999.17.3.1029
20. Rivers D, August E, Sehovic I, et al. A systematic review of the factors influencing African Americans’
participation in cancer clinical trials. Elsevier. 2013;35(2):13–32.
21. Hamel L, Penner L, Albrecht T, et al. Barriers to clinical trial enrollment in racial and ethnic minority
patients with cancer. Author manuscript. 2016;23(4):327–337.
22. Swaby J, Kaninjing E, Ogunsanya M. African American participation in cancer clinical trials.
Ecancermedicalscience. 2021;15:1307.
23. Scharff D, Mathews K, Jackson P, et al. More than Tuskegee: understanding mistrust about research
participation. HHS Author Manuscripts. 2010;21(3):879–897.
24. Kanarek N, Tsai H, Gaud S, et al. Geographic proximity and racial disparities in cancer clinical trial
participation. J Natl Compr Canc Netw. 2010;8(12):1343–1351. doi:10.6004/jnccn.2010.0102
25. Fayanju O, Ren Y, Thomas S, et al. A case-control study examining disparities in clinical trial participation
among breast surgical oncology patients. JNCI Cancer Spectrum. 2020;4(2):pkz103.
26. Echeverri M, Anderson D, Napoles A, et al. Cancer health literacy and willingness to participate in
cancer research and donate bio-specimens. International Journal of Environmental Research and Public
Health. 2018;15:2091.
27. Sudore R, Landefeld C, Williams B, et al. Use of a modified informed consent process among vulnerable
patients: A Descriptive Study. 2006;21(8):867–873.
28. Brawley, O. The study of untreated syphilis in the negro male. Int J Radiat Oncol Biol Phys. 1998;40(1):5–
8. doi:10.1016/s0360-3016(97)00835-3.
29. Park J. Historical origins of the Tuskegee experiment: the dilemma of public health in the United States.
Uisahak. 2017;26(3):545–578. doi:10.13081/kjmh.2017.26.545
SOCRA SOURCE © May 2023
59